Recent Quotes (30 days)

You have no recent quotes
chg | %

GlaxoSmithKline plc news

   Watch this stock
Showing stories 1 - 10 of about 166   

Articles published

GSK 1,322.50 -23.00 (-1.71%)
price chart
4 Shares Yielding More Than 5%: GlaxoSmithKline plc, SSE plc, Infinis Energy ...
GlaxoSmithKline (LSE: GSK) is struggling with the increase in generic competition, as its major blockbuster drugs lose patent protection.
Do Price Falls Make Banco Santander SA, Centrica PLC And GlaxoSmithKline ...
We usually hear much wailing when the FTSE 100 falls, and it's down around 100 points today due to what's happening in Greece.
4 Reasons Why GlaxoSmithKline plc Is One Of The Best Dividend Stocks That ...
Following a tough 2014, shares in GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) have disappointed since the turn of the year.
GlaxoSmithKline plc Earns "A+" Credit Rating (GSK)  Dakota Financial News
Pharma Showdown: Should You Buy GlaxoSmithKline plc Or Shire PLC?
If you're struggling to choose between GlaxoSmithKline (LSE: GSK) and Shire (LSE: SHP), you're not alone. Glaxo and Shire are two of the UK's premier pharmaceutical companies, with their individual strengths and weaknesses. And choosing between the ...
Why Ashmore Group plc, GlaxoSmithKline plc, Keller Group plc & GKN plc Look ...
I believe that shares in Ashmore (LSE: ASHM) are due for a bounce as conditions in key emerging market improve. The business has suffered from weakened client activity over the past year, but with cyclical problems now abating and the financial ...
3 Shares Analysts Hate: GlaxoSmithKline plc, Standard Chartered PLC And ...
It wasn't so long ago that GlaxoSmithKline was the City experts' favoured pharmaceuticals firm, while AstraZeneca was thoroughly unloved.
Should You Buy GlaxoSmithKline plc, Hikma Pharmaceuticals Plc Or Indivior PLC?
Shares in income favourite GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) have fallen by nearly 15% over the last three months, and by 7% so far in June.
Neil Woodford Buys Horizon Discovery Group PLC And More GlaxoSmithKline ...
Ace fund manager Neil Woodford engaged in a good deal of trading during May. His flagship CF Woodford Equity Income Fund was active in the blue-chip arena, but also bought into a number of new small caps.
As GlaxoSmithKline plc Nears A 52-Week Low, Is It Time To Buy?
2015 is shaping up to be a pretty terrible year for GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US). Year to date, the company's shares have hardly budged while the rest of the FTSE All World Pharma & Biotech sector has risen by 10%.
BP plc vs GlaxoSmithKline plc: Which Is The King Of The FTSE 100?
The last year has been hugely disappointing for investors in BP (LSE: BP) (NYSE: BP.US) and GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US), with the share prices of the two companies both falling by 11%. And, while neither of them are the biggest stock in ...
Zacks Rating on GlaxoSmithKline PLC  American Trade Journal